Search research articles
Contact Us
Filters
Showing results (51-60 of 149) with videos related to
Page
of 15
Sort By:
European Journal of Clinical Pharmacology
|
August 11, 1998
Effect of meal timing on the kinetic-dynamic profile of levodopa/carbidopa controlled release [corrected] in parkinsonian patients
M Contin, R Riva, P Martinelli, et al.
Clinical Chemistry
|
January 1, 1985
High alpha 1-acid glycoprotein concentrations in serum of epileptic children being treated with carbamazepine
R Riva, M Contin, F Albani, et al.
Seizure
|
May 4, 2004
Immediate (overnight) switching from carbamazepine to oxcarbazepine monotherapy is equivalent to a progressive switch
F Albani, B Grassi, R Ferrara, et al.
Clinical Neuropharmacology
|
December 1, 1992
No effect of chronic bromocriptine therapy on levodopa pharmacokinetics in patients with Parkinson's disease
M Contin, R Riva, P Martinelli, et al.
Headache
|
May 1, 1990
Flunarizine plasma concentrations and side effects in migraine patients
F Albani, A Baldrati, P Cortelli, et al.
Bollettino Chimico Farmaceutico
|
December 1, 1981
[Bioavailability of phenytoin. Comparison of data obtained in vitro, in healthy volunteers and in epileptic patients]
F Albani, P Pazzaglia, G Procaccianti, et al.
Sleep
|
January 1, 1980
Cerebrospinal fluid homovanillic acid and 5-hydroxyindoleacetic acid in hypersomnia with periodic apneas or idiopathic hypersomnia: preliminary results
A Baruzzi, F Cirignotta, G Coccagna, et al.
European Journal of Clinical Pharmacology
|
January 1, 1991
Effect of age on the pharmacokinetics of oral levodopa in patients with Parkinson's disease
M Contin, R Riva, P Martinelli, et al.
Epilepsy Research
|
September 28, 2011
Levetiracetam clinical pharmacokinetics in elderly and very elderly patients with epilepsy
M Contin, S Mohamed, F Albani, et al.
Muscle & Nerve
|
April 24, 2001
Familial continuous motor unit activity and epilepsy
R Liguori, P Avoni, A Baruzzi, et al.
Page
of 15
Search research articles
Search
Showing results (51-60 of 149) with videos related to
Sort By:
Page
of 15
European Journal of Clinical Pharmacology
|
August 11, 1998
Effect of meal timing on the kinetic-dynamic profile of levodopa/carbidopa controlled release [corrected] in parkinsonian patients
M Contin, R Riva, P Martinelli, et al.
Clinical Chemistry
|
January 1, 1985
High alpha 1-acid glycoprotein concentrations in serum of epileptic children being treated with carbamazepine
R Riva, M Contin, F Albani, et al.
Seizure
|
May 4, 2004
Immediate (overnight) switching from carbamazepine to oxcarbazepine monotherapy is equivalent to a progressive switch
F Albani, B Grassi, R Ferrara, et al.
Clinical Neuropharmacology
|
December 1, 1992
No effect of chronic bromocriptine therapy on levodopa pharmacokinetics in patients with Parkinson's disease
M Contin, R Riva, P Martinelli, et al.
Headache
|
May 1, 1990
Flunarizine plasma concentrations and side effects in migraine patients
F Albani, A Baldrati, P Cortelli, et al.
Bollettino Chimico Farmaceutico
|
December 1, 1981
[Bioavailability of phenytoin. Comparison of data obtained in vitro, in healthy volunteers and in epileptic patients]
F Albani, P Pazzaglia, G Procaccianti, et al.
Sleep
|
January 1, 1980
Cerebrospinal fluid homovanillic acid and 5-hydroxyindoleacetic acid in hypersomnia with periodic apneas or idiopathic hypersomnia: preliminary results
A Baruzzi, F Cirignotta, G Coccagna, et al.
European Journal of Clinical Pharmacology
|
January 1, 1991
Effect of age on the pharmacokinetics of oral levodopa in patients with Parkinson's disease
M Contin, R Riva, P Martinelli, et al.
Epilepsy Research
|
September 28, 2011
Levetiracetam clinical pharmacokinetics in elderly and very elderly patients with epilepsy
M Contin, S Mohamed, F Albani, et al.
Muscle & Nerve
|
April 24, 2001
Familial continuous motor unit activity and epilepsy
R Liguori, P Avoni, A Baruzzi, et al.
Page
of 15